Effect of polyanion-resistance on HIV-1 infection

被引:19
|
作者
Bobardt, MD
Armand-Ugón, M
Clotet, I
Zhang, Z
David, G
Este, JA
Gallay, PA
机构
[1] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[2] Hosp Germans Trias & Pujol, Retrovirol Lab IrsiCaixa, Badalona 08916, Spain
[3] Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium
[4] Flanders Interuniv Inst Biotechnol, B-3000 Louvain, Belgium
关键词
polyanion; HIV-1; T cell;
D O I
10.1016/j.virol.2004.05.011
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Polyanions are potent HIV-1 entry inhibitors. Nevertheless, resistant viruses may emerge under polyanion inhibitory pressure. Specifically.. a polyanion-resistant virus replicates in T cells even in the presence of high concentrations of polyanions. We found that although the polyanion-resistant virus grows in suspension CD4+ T cells efficiently, it infects nonlymphocytic adherent CD4+ cells poorly. Given that a main distinction between suspension and adherent cells is the absence or presence of cell-surface heparan sulfate proteoglycan (HSPG), we investigated if the failure of the polyanion-resistant virus to infect adherent CD4+ cells arises from its inability to bind HSPG. We found that the emergence of mutations in gp120 associated with polyanion resistance resulted in a decreased capacity of HIV-1 to bind HSPG. We also found that the polycation polybrene rescued the capacity of the polyanion-resistant virus to bind HSPG and to infect adherent CD4+ cells. The identification of this virus, unable to bind HSPG, provides a convenient probe to measure the impact of HIV-1-HSPG interactions in vivo. Altogether, these findings suggest that polyanion-resistance narrows the range of potential target cells for HIV-1 in the host. This reinforces the hypothesis that cell-free or cell-associated polyanions such as HSPG possess the capacity to modulate HIV-1 pathogenesis. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:389 / 398
页数:10
相关论文
共 50 条
  • [31] Intrafamilial transmission of HIV-1 infection from individuals with unrecognized HIV-1 infection
    French, MA
    Herring, BL
    Kaldor, JM
    Sayer, DC
    Furner, V
    de Chaneet, CC
    Dwyer, DE
    AIDS, 2003, 17 (13) : 1977 - 1981
  • [32] Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
    Liu, R
    Paxton, WA
    Choe, S
    Ceradini, D
    Martin, SR
    Horuk, R
    MacDonald, ME
    Stuhlmann, H
    Koup, RA
    Landau, NR
    CELL, 1996, 86 (03) : 367 - 377
  • [33] Immunotherapies in HIV-1 infection
    Pett, Sarah L.
    CURRENT OPINION IN HIV AND AIDS, 2009, 4 (03) : 188 - 193
  • [34] SINUSITIS IN HIV-1 INFECTION
    ZURLO, JJ
    FEUERSTEIN, IM
    LEBOVICS, R
    LANE, HC
    AMERICAN JOURNAL OF MEDICINE, 1992, 93 (02): : 157 - 162
  • [35] THE NEUROPATHOGENESIS OF HIV-1 INFECTION
    GENDELMAN, HE
    LIPTON, SA
    TARDIEU, M
    BUKRINSKY, MI
    NOTTET, HSLM
    JOURNAL OF LEUKOCYTE BIOLOGY, 1994, 56 (03) : 389 - 398
  • [36] Neopterin in HIV-1 infection
    Wirleitner, B
    Schroecksnadel, K
    Winkler, C
    Fuchs, D
    MOLECULAR IMMUNOLOGY, 2005, 42 (02) : 183 - 194
  • [37] The pathogenesis of HIV-1 infection
    Weber, J
    BRITISH MEDICAL BULLETIN, 2001, 58 : 61 - 72
  • [38] HIV-1 infection in China
    Neild, PJ
    Gazzard, BG
    LANCET, 1997, 350 (9082): : 963 - 963
  • [39] Macrophage Resistance to HIV-1 Infection Is Enhanced by the Neuropeptides VIP and PACAP
    Temerozo, Jairo R.
    Joaquim, Rafael
    Regis, Eduardo G.
    Savino, Wilson
    Bou-Habib, Dumith Chequer
    PLOS ONE, 2013, 8 (06):
  • [40] HLA-associated susceptibility/resistance factors for HIV-1 infection
    RohowskyKochan, C
    Eiman, D
    Skurnick, J
    Louria, D
    FASEB JOURNAL, 1996, 10 (06): : 367 - 367